NWAM LLC’s Biogen BIIB Stock Holding History

NWAM LLC’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$209K	Buy	+1,141	New	+$210K	0.01%	587
2024 Q4	–	Sell	-1,152	Closed	-$223K	–	597
2024 Q3	$223K	Sell	1,152 -173	-13%	-$36.2K	0.01%	567
2024 Q2	$307K	Buy	1,325 +1	+0.1%	+$217	0.09%	110
2024 Q1	$290K	Buy	1,324 +78	+6%	+$18.3K	0.02%	440
2023 Q4	$322K	Buy	1,246 +80	+7%	+$19.6K	0.03%	424
2023 Q3	$300K	Sell	1,166 -92	-7%	-$24.6K	0.03%	387
2023 Q2	$358K	Sell	1,258 -7	-0.6%	-$2.08K	0.03%	381
2023 Q1	$352K	Buy	1,265 +5	+0.4%	+$1.38K	0.04%	335
2022 Q4	$349K	Sell	1,260 -49	-4%	-$13.8K	0.03%	386
2022 Q3	$350K	Buy	1,309 +118	+10%	+$25.1K	0.03%	357
2022 Q2	$253K	Sell	1,191 -493	-29%	-$101K	0.02%	436
2022 Q1	$355K	Sell	1,684 -6	-0.4%	-$1.3K	0.03%	388
2021 Q4	$405K	Buy	+1,690	New	+$435K	0.03%	364

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NWAM LLC's BIIB Position: Q1 2026 in Review

NWAM LLC opened a new position in Biogen (BIIB) in Q1 2026: 1,141 shares worth $209K. The stake represents 0.01% of the portfolio and ranks #587 among its holdings. This is a return to the name: NWAM LLC previously reported a position in BIIB as recently as Q3 2024.

NWAM LLC first reported a position in BIIB in Q4 2021 and has held it in 13 quarters since. The position peaked at $405K in Q4 2021. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

NWAM LLC held 1,141 shares of Biogen worth $209K as of Q1 2026.
Biogen was a new NWAM LLC position in Q1 2026.
Biogen made up 0.01% of NWAM LLC's portfolio in Q1 2026, its #587 holding.
NWAM LLC first reported a position in Biogen in Q4 2021 and has held it in 13 quarters since.
NWAM LLC's Biogen position peaked at $405K in Q4 2021.
1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on NWAM LLC's 13F filing for Q1 2026, filed 4 May 2026.